Cargando…
Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer in Korea
PURPOSE: Letrozole showed efficacy and generally favorable toxicities, along with the convenience of oral administration in postmenopausal patients with hormone receptor (HR)–positive metastatic breast cancer (MBC). To the best of our knowledge, there have been no reports of the clinical outcomes in...
Autores principales: | Beom, Seung Hoon, Oh, Jisu, Kim, Tae-Yong, Lee, Kyung-Hun, Yang, Yaewon, Suh, Koung Jin, Moon, Hyeong-Gon, Han, Sae-Won, Oh, Do-Youn, Han, Wonshik, Kim, Tae-You, Noh, Dong-Young, Im, Seock-Ah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398408/ https://www.ncbi.nlm.nih.gov/pubmed/27554482 http://dx.doi.org/10.4143/crt.2016.259 |
Ejemplares similares
-
Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses
por: Yang, Yaewon, et al.
Publicado: (2016) -
Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer Patients
por: Yang, Yaewon, et al.
Publicado: (2020) -
Immune recurrence score using 7 immunoregulatory protein expressions can predict recurrence in stage I–III breast cancer patients
por: Lee, Dae-Won, et al.
Publicado: (2019) -
Adenoid Cystic Carcinoma of the Breast: A Case Series of Six Patients and Literature Review
por: Kim, Miso, et al.
Publicado: (2014) -
Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)
por: Kim, Jisun, et al.
Publicado: (2014)